Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Safety Study of Gleevec® in Children With Pulmonary Hypertension

Phase 2

Terminated

Conditions: Pulmonary Hypertension

Interventions: Drug: Gleevec

First Posted Date: 2007-12-31

Last Posted Date: 2015-10-29

Lead Sponsor: Indiana University

Target Recruit Count: 1

Registration Number: NCT00583115

Locations: 🇺🇸
Indiana University School of Medicine; Riley Hospital for Children, Indianapolis, Indiana, United States

A Prospective Study of EUS Guided Celiac Block

Completed

Conditions: Pancreatic Cancer
Chronic Pancreatitis

Interventions: Drug: 98% dehydrated alcohol
Drug: triamcinolone

First Posted Date: 2007-12-31

Last Posted Date: 2014-09-05

Lead Sponsor: Indiana University

Target Recruit Count: 127

Registration Number: NCT00583271

Locations: 🇺🇸
Clarian Health: Indiana University Hospital, Indianapolis, Indiana, United States

Hypertension in Hemodialysis Patients (Aim 3)

Phase 3

Terminated

Conditions: Left Ventricular Hypertrophy
Hemodialysis
Hypertension

Interventions: Drug: Lisinopril
Drug: Atenolol

First Posted Date: 2007-12-28

Last Posted Date: 2016-01-18

Lead Sponsor: Indiana University

Target Recruit Count: 200

Registration Number: NCT00582114

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study

Phase 4

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: dehydrated alcohol

First Posted Date: 2007-12-21

Last Posted Date: 2012-10-19

Lead Sponsor: Indiana University

Target Recruit Count: 20

Registration Number: NCT00578279

Locations: 🇺🇸
Clarian Health: Indiana University Hospital, Indianapolis, Indiana, United States

Lung Cancer Location: a Repository

Terminated

Conditions: Lung Cancer

First Posted Date: 2007-12-20

Last Posted Date: 2013-10-08

Lead Sponsor: Indiana University

Target Recruit Count: 200

Registration Number: NCT00578084

Locations: 🇺🇸
Clarian/IUPUI: University Hospital, Indianapolis, Indiana, United States

EUS-CPN: A Retrospective Review

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2007-12-20

Last Posted Date: 2012-09-12

Lead Sponsor: Indiana University

Registration Number: NCT00577564

Locations: 🇺🇸
Clarian: University Hospital, Indianpolis, Indiana, United States

Prevalence of Lymphoma in IBD

Completed

Conditions: Lymphoma
Inflammatory Bowel Disease

First Posted Date: 2007-12-20

Last Posted Date: 2015-08-10

Lead Sponsor: Indiana University

Target Recruit Count: 7

Registration Number: NCT00577538

Locations: 🇺🇸
Indiana University Medical Center, Indianapolis, Indiana, United States

Value of Fecal Calprotectin

Completed

Conditions: Calprotectin
Inflammatory Bowel Disease

First Posted Date: 2007-12-20

Last Posted Date: 2015-08-10

Lead Sponsor: Indiana University

Target Recruit Count: 171

Registration Number: NCT00577928

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

Hospital Acquired and Community Acquired MRSA in GI Lab

Withdrawn

Conditions: Community Acquired MRSA
Hospital Acquired MRSA

First Posted Date: 2007-12-20

Last Posted Date: 2016-03-01

Lead Sponsor: Indiana University

Registration Number: NCT00577343

Locations: 🇺🇸
Clarian/Indiana University Hospital, Indianapolis, Indiana, United States

Clinical Impact of EUS in Staging NSCLC

Completed

Conditions: Non Small Cell Lung

First Posted Date: 2007-12-20

Last Posted Date: 2014-09-05

Lead Sponsor: Indiana University

Target Recruit Count: 110

Registration Number: NCT00577746

Locations: 🇺🇸
Indiana University Medical Center; Clarian Health, Indianapolis, Indiana, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy